$ADHC Long
Good play on a speculative migraine pain management device.
Around 600 M shares outstanding with low float and virtually no debt.
A small investment in
ADHC could yield exponential returns in a few short years.
Market cap could exceed to over 11B+ with successful FDA and clinical studies then successful marketplace execution.
Over $1 PPS is not unreasonable with this massive pain management market.
Good luck to longs.
Around 600 M shares outstanding with low float and virtually no debt.
A small investment in
ADHC could yield exponential returns in a few short years. Market cap could exceed to over 11B+ with successful FDA and clinical studies then successful marketplace execution.
Over $1 PPS is not unreasonable with this massive pain management market.
Good luck to longs.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.